Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 27, 2021New England Journal of MedicineOpen Access

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

View Full Paper
Ask AI
Bookmark
Share

Authors

RFRobert W. FrenckUniversity of Maryland, BaltimoreNKNicola P. KleinKaiser PermanenteNKNicholas KitchinPfizer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Frenck et al. (2021) studied this question.

synapsesocial.com/papers/6a1be8964ebd09f3dfa932b1https://doi.org/10.1056/nejmoa2107456
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Debate: The impact of school closures and lockdown on mental health in young people2020 · 51 citations
  2. 2First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 20212021 · 419 citations
  3. 3SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp — Georgia, June 20202020 · 242 citations
  4. 4Schools Closures During the COVID-19 Pandemic2021 · 154 citations
  5. 5Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2020 · 2,754 citations